Anti-il-tif antibodies and methods of using in inflammation
AssigneeZymoGenetics, Inc.
InventorsWenfeng Xu, Wayne Kindsvogel, Steven D. Hughes, Yasmin A. Chandrasekher
Life of this patent
Estimating the term…
Abstract
The present invention relates to blocking the activity of IL-TIF polypeptide molecules. IL-TIF is a cytokine involved in inflammatory processes and human disease. The present invention includes anti-IL-TIF antibodies and binding partners, as well as methods for antagonizing IL-TIF using such antibodies and binding partners in IL-TIF-related human inflammatory diseases, amongst other uses disclosed.
Claims4
A method for inhibiting IL-TIF-induced proliferation or differentiation of hematopoietic cells and hematopoietic cell progenitors, wherein the method comprises culturing bone marrow or peripheral blood cells with a composition comprising an amount of an antibody sufficient to reduce proliferation or differentiation of the hematopoietic cells in the bone marrow or peripheral blood cells as compared to bone marrow or peripheral blood cells cultured in the absence of soluble cytokine receptor,
- wherein the antibody is produced by a method comprising inoculating an animal with a polypeptide, wherein said polypeptide consists of the amino acid sequence of SEQ ID NO:34, wherein the polypeptide elicits an immune response in the animal to produce the antibody;
- and isolating the antibody from the animal.
A method of reducing IL-TIF-induced inflammation comprising administering to a mammal with inflammation an amount of a composition of an antibody sufficient to reduce inflammation,
- wherein the antibody is produced by a method comprising inoculating an animal with a polypeptide, wherein said polypeptide consists of the amino acid sequence of SEQ ID NO:34, wherein the polypeptide elicits an immune response in the animal to produce the antibody;
- and isolating the antibody from the animal.
Dependencies are inferred from the claim text.